Type of analysis | HR | SE | 95% CI | P-value |
---|
VTE risk
|
Crude analysis | 0.66 | 0.29 | (0.28-1.54) | 0.33 |
PS stratified analysis* | 0.63 | 0.29 | (0.25-1.57) | 0.33 |
Hospital Mortality
|
Crude analysis | 1.26 | 0.18 | (0.95-1.68) | 0.10 |
PS stratified analysis* | 0.98 | 0.16 | (0.72-1.36) | 0.94 |
- *Adjusted for age, APACHE II score, GCS, creatinine, INR, aPTT, Trauma, femoral fracture, central line presence, malignancy, recent surgery, previous VTE, hemodialysis catheter use, use of graduated compression stocking, use of sequential compression device, DVT prophylaxis with unfractionated heparin or enoxaparin, and platelet transfusion.